Evolution Advisers’s Acadia Healthcare ACHC Stock Holding History

Evolution Advisers’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+9	New	+$231	﹤0.01%	211

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Evolution Advisers's ACHC Position: Q2 2026 in Review

Evolution Advisers opened a new position in Acadia Healthcare (ACHC) in Q2 2026: 9 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #211 among its holdings.

313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Evolution Advisers held 9 shares of Acadia Healthcare worth $0 as of Q2 2026.
Acadia Healthcare was a new Evolution Advisers position in Q2 2026.
Acadia Healthcare made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #211 holding.
313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.